Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 01, 2011 (Vol. 31, No. 9)

MassBank

URL:www.massbank.jp/index.html?lang=en
  • Great site design, many search features
  • Nothing major

When you’re a bank whose currency is the charge-to-mass ratio, you certainly don’t need to trouble yourself with the ongoing economic crisis! Such is the situation for MassBank, a high-resolution mass spectral database (and the official mass spectral database of The Mass Spectrometry Society of Japan, no less!). The website is beautifully designed, and the database can be searched a variety of ways: one can search similar spectra on a peak-to-peak basis, search by chemical compound name or molecular formula, search spectra by the molecular formula and the m/z value, search chemical compounds by substructures, or search similar spectra that are similar to the user’s spectrum based on molecular formula. Additionally, there is a neat 3-D viewer to directly compare spectra. So don’t just take my word for it—listen to people of the Mass Spectrometry Society of Japan and go check out this site.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »